Accelerating glycoscience research
I'm Chris, an Australian glycoscientist who has studied the field for >10 years now (across both AU and US), starting (MRes and PhD) in the lab of Prof. Nicki Packer.
I believe LC-MS glyco still has a lot to discover.
--> computationalproteomics.khoury.northeastern.edu
--> computationalproteomics.khoury.northeastern.edu
Boosting the Speed and Accuracy of Protein Quantification Algorithms in Mass Spectrometry-Based Proteomics | Journal of Proteome Research pubs.acs.org/doi/10.1021/...
Boosting the Speed and Accuracy of Protein Quantification Algorithms in Mass Spectrometry-Based Proteomics | Journal of Proteome Research pubs.acs.org/doi/10.1021/...
I’ll still submit an abstract, but who knows what the state of the world will be in June.
I’ll still submit an abstract, but who knows what the state of the world will be in June.
This is a cool open-source implementation that even works on an Orbitrap Elite! #teammassspec
This is a cool open-source implementation that even works on an Orbitrap Elite! #teammassspec
The numbers are massive: calculations suggest about 20 to 200 million N-glycans per human cell!
Read the full blog post: research.bidmc.org/ncfg/blog/24...
#glycobiology #glycotime #cells #biology
Brilliant retrospective by @richardsever.bsky.social on the origins, growth and resounding success of bioRxiv and medRxiv ⬇️
journals.asm.org/doi/10.1128/...
Brilliant retrospective by @richardsever.bsky.social on the origins, growth and resounding success of bioRxiv and medRxiv ⬇️
journals.asm.org/doi/10.1128/...
---
#proteomics #prot-preprint
---
#proteomics #prot-preprint
#glycotime #CarbohydrateResearch
#glycotime #CarbohydrateResearch
22 funded postdoc projects in data-driven life science, with academic and industry tracks
Call details:
www.scilifelab.se/data-driven/...
Matchmaking platform:
www.scilifelab.se/data-driven/...
#postdoc #DDLS #SciLifeLab #researchjobs
22 funded postdoc projects in data-driven life science, with academic and industry tracks
Call details:
www.scilifelab.se/data-driven/...
Matchmaking platform:
www.scilifelab.se/data-driven/...
#postdoc #DDLS #SciLifeLab #researchjobs
#glycotime #GlycoconjugateJournal
#glycotime #GlycoconjugateJournal
Leveraging Mirror-Image Glycans in #CarbohydrateMaterials out today in @orgbiomolchem.rsc.org !
@rsc.org, @mpici.bsky.social
pubs.rsc.org/en/content/a...
Leveraging Mirror-Image Glycans in #CarbohydrateMaterials out today in @orgbiomolchem.rsc.org !
@rsc.org, @mpici.bsky.social
pubs.rsc.org/en/content/a...
"Adnan et al. introduced fragment ion (m/z 138 + m/z 168) to (m/z 126 + m/z 144) RA ratios"
"we proposed a new diagnostic clue to distinguish...the RA ratio of fragment ions at m/z 126.055 and 138"
"Adnan et al. introduced fragment ion (m/z 138 + m/z 168) to (m/z 126 + m/z 144) RA ratios"
"we proposed a new diagnostic clue to distinguish...the RA ratio of fragment ions at m/z 126.055 and 138"
Thought I'd give it a try:
💻+⏱️+(🦠/🐟)=🧁⚡♦️
How about yours?
Thought I'd give it a try:
💻+⏱️+(🦠/🐟)=🧁⚡♦️
How about yours?
Thermo/Waters -> Multi-channel (in parallel) IMS pre- and post- separation (similar approach to Bruker)
Bruker -> New sample introduction for MALDI (Flex upgrade incoming 2026?)
Sciex -> Peptide negative EAD (Should be on the 9600)
Mobilion -> Iterative IMS
Thermo/Waters -> Multi-channel (in parallel) IMS pre- and post- separation (similar approach to Bruker)
Bruker -> New sample introduction for MALDI (Flex upgrade incoming 2026?)
Sciex -> Peptide negative EAD (Should be on the 9600)
Mobilion -> Iterative IMS
www.biorxiv.org/content/10.6...
My first preprint!
An instrument capablity comparison for #proteomics for #biomanufacturing. Working towards the economical appliction of #omics technologies to industrial life science.
www.biorxiv.org/content/10.6...
My first preprint!
An instrument capablity comparison for #proteomics for #biomanufacturing. Working towards the economical appliction of #omics technologies to industrial life science.
"No longer could people rely on the content, because the cost of creating fake material was so low, and the benefits so high. Now an academic could possibly publish half a dozen articles in a year, mostly because they could submit a hundred and hope a few got through"
"No longer could people rely on the content, because the cost of creating fake material was so low, and the benefits so high. Now an academic could possibly publish half a dozen articles in a year, mostly because they could submit a hundred and hope a few got through"